Domenico Albino
Overview
Explore the profile of Domenico Albino including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
594
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cacciatore A, Shinde D, Musumeci C, Sandrini G, Guarrera L, Albino D, et al.
Nat Commun
. 2024 Aug;
15(1):6672.
PMID: 39107274
Castration-resistant prostate cancer (CRPC) is a frequently occurring disease with adverse clinical outcomes and limited therapeutic options. Here, we identify methionine adenosyltransferase 2a (MAT2A) as a critical driver of the...
2.
Cacciatore A, Albino D, Catapano C, Carbone G
Curr Protoc
. 2023 May;
3(5):e742.
PMID: 37166213
Prostate cancer (PCa) is the most common malignancy and the second leading cause of cancer-related death amongst men in the United States. Neuroendocrine prostate cancer (NEPC) can either arise de...
3.
Zoma M, Curti L, Shinde D, Albino D, Mitra A, Sgrignani J, et al.
Nat Commun
. 2021 Jul;
12(1):4147.
PMID: 34230470
The TMPRSS2-ERG gene fusion is the most frequent alteration observed in human prostate cancer. However, its role in disease progression is still unclear. In this study, we uncover an important...
4.
Bernasocchi T, El Tekle G, Bolis M, Mutti A, Vallerga A, Brandt L, et al.
Nat Commun
. 2021 Feb;
12(1):734.
PMID: 33531470
Driver genes with a mutually exclusive mutation pattern across tumor genomes are thought to have overlapping roles in tumorigenesis. In contrast, we show here that mutually exclusive prostate cancer driver...
5.
Albino D, Falcione M, Uboldi V, Temilola D, Sandrini G, Merulla J, et al.
Commun Biol
. 2021 Jan;
4(1):119.
PMID: 33500545
Extracellular vesicles (EVs) are relevant means for transferring signals across cells and facilitate propagation of oncogenic stimuli promoting disease evolution and metastatic spread in cancer patients. Here, we investigated the...
6.
Mapelli S, Albino D, Mello-Grand M, Shinde D, Scimeca M, Bonfiglio R, et al.
Cancers (Basel)
. 2020 Oct;
12(10).
PMID: 33066424
There is an error in the title of the paper [...].
7.
Mapelli S, Albino D, Mello-Grand M, Shinde D, Scimeca M, Bonfiglio R, et al.
Cancers (Basel)
. 2020 Jan;
12(1).
PMID: 31936761
In this study, we extracted prostate cell-specific gene sets (metagenes) to define the epithelial differentiation status of prostate cancers and, using a deconvolution-based strategy, interrogated thousands of primary and metastatic...
8.
Scaruffi P, Moretti S, Coco S, Mazzocco K, Defferrari R, Albino D, et al.
Cancer Genomics Proteomics
. 2019 Aug;
3(3-4):245-252.
PMID: 31394704
Neuroblastoma (NB) is one of the most common paediatric solid tumours and displays a broad variety of genomic alterations. Recently, array comparative genomic hybridization (aCGH) has emerged as a novel...
9.
Shinde D, Albino D, Zoma M, Mutti A, Mapelli S, Civenni G, et al.
Eur Urol Oncol
. 2019 Jul;
2(4):415-424.
PMID: 31277777
Background: The TMPRSS2-ERG gene fusion is the most frequent genetic rearrangement in prostate cancers and results in broad transcriptional reprogramming and major phenotypic changes. Interaction and cooperation of ERG and...
10.
Civenni G, Albino D, Shinde D, Vazquez R, Merulla J, Kokanovic A, et al.
Front Oncol
. 2019 May;
9:385.
PMID: 31143708
Prostate cancer is the most common malignancy in men and the second cause of cancer-related deaths in western countries. Despite the progress in the treatment of localized prostate cancer, there...